Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 9/20 | 1.00 |
| ▸ | GSK3A | P49840 | 9/20 | 1.00 |
| ▸ | CDK2 | P24941 | 5/20 | 1.00 |
| ▸ | AAK1 | Q2M2I8 | 9/20 | 0.71 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.71 |
| ▸ | PIM1 | P11309 | 1/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4491509 | 0.95 | GSK3B (0.91) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4494232 | 0.95 | GSK3B (0.91) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4487631 | 0.84 | GSK3B (0.75) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4486435 | 0.84 | GSK3B (0.85) | GSK3BGSK3ACDK2CYP1A2HDAC1 | |
| SCHEMBL4500013 | 0.83 | GSK3A (1.00) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4492445 | 0.83 | GSK3B (0.70) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4503726 | 0.83 | GSK3B (0.70) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4493549 | 0.82 | GSK3B (0.80) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4484280 | 0.82 | AAK1 (0.80) | GSK3BGSK3ACDK2AAK1PIK3CD | |
| SCHEMBL4492221 | 0.82 | GSK3B (0.69) | GSK3BGSK3ACDK2AAK1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |